Finance

Lists
N3B:FRA
Anbio Biotechnology
€9.00
+13.21%
(+1.05) 1D
Jul 24, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for N3B...
Open
€8.40
High
€9.00
Low
€8.25
Mkt. cap
434.52M
Avg. vol.
4.00
Volume
5.00
52-wk high
€43.60
52-wk low
€7.70
No. of employees
27
Open
€8.40
High
€9.00
Low
€8.25
Mkt. cap
434.52M
Avg. vol.
4.00
Volume
5.00
52-wk high
€43.60
52-wk low
€7.70
No. of employees
27
News stories
From sources across the web
About Anbio Biotechnology
CEO-
Employees27
Founded2021
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.29M
2.29M
2.03M
2.03M
Cost of goods sold
175.97K
175.97K
375.87K
375.87K
Cost of revenue
175.97K
175.97K
375.87K
375.87K
Research and development expenses
65.65K
65.65K
35.00K
35.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
367.06K
367.06K
420.00K
420.00K
Operating expense
432.72K
432.72K
455.00K
455.00K
Total operating expenses
608.68K
608.68K
830.87K
830.87K
Operating income
1.68M
1.68M
1.20M
1.20M
Other non operating income
69.00
69.00
-
-
EBT including unusual items
1.90M
1.90M
1.30M
1.30M
EBT excluding unusual items
1.98M
1.98M
1.25M
1.25M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
1.90M
1.90M
1.30M
1.30M
Net profit margin
82.84%
82.84%
64.14%
64.14%
Earnings per share
-
-
-
-
Interest and investment income
70.12K
70.12K
34.89K
34.89K
Interest expense
-
-
-
-
Net interest expenses
70.12K
70.12K
34.89K
34.89K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more